Physician profile
James Weltman
NPI 1306263579
$1,129.33
in general payments reported to CMS, 2019-2025
18 companies · $376 in 2025
The $376 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $188 · 2022: $159 · 2023: $277 · 2024: $130 · 2025: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $758 · Education: $24.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $757.73 |
| Education | $24.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $270.72 | 2021-2023 | Farxiga |
| Akebia Therapeutics INC | $142.11 | 2023-2025 | Vafseo, Auryxia |
| Otsuka America Pharmaceutical, INC. | $141.46 | 2022-2025 | Jynarque |
| Bayer Healthcare Pharmaceuticals INC. | $100.05 | 2021-2025 | |
| Calliditas Therapeutics US INC. | $80.17 | 2022-2023 | Tarpeyo |
| Glaxosmithkline, LLC. | $69.83 | 2023-2025 | Benlysta, Jesduvroq |
| Vifor Pharma, INC. | $55.33 | 2022-2025 | Veltassa, Korsuva |
| Amgen INC. | $47.84 | 2022-2025 | Krystexxa |
| Aurinia Pharma U.S., INC. | $32.50 | 2022-2023 | Lupkynis |
| Travere Therapeutics, INC. | $29.64 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.69 | 2025 | Jardiance |
| Horizon Therapeutics Plc | $22.82 | 2023 | Krystexxa |
| Genzyme Corporation | $22.23 | 2025 | |
| Ardelyx, INC. | $20.95 | 2024 | Ibsrela |
| Alexion Pharmaceuticals, INC. | $18.98 | 2023 | Ultomiris |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cormedix INC. | $18.20 | 2024 | Defencath |
| Mallinckrodt Hospital Products INC. | $16.02 | 2025 | Acthar |
| Bard Peripheral Vascular, INC. | $15.79 | 2025 | Powerport Clearvue Isp Implantable Port |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Weltman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.